Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia

rifosine plus bortezomib, there were 2 PR's and 1 MR. Two additional MR's were observed on this combination after dexamethasone was added; both of these patients were previously refractory to the combination of bortezomib + dexamethasone without perifosine. Eleven patients remain on study and the phase II portion of the study is now open and enrolling.

A second poster presented by Dr. Richardson, entitled " Perifosine (KRX- 0401) + Low Dose Dexamethasone is Active in Patients with Relapsed and Refractory Multiple Myeloma (MM): Perifosine MM Investigator Group Phase II Multicenter Study Update" demonstrated that 78% of patients treated with perifosine plus low dose dexamethasone had at least stable disease (SD), including 26% that had a PR or MR. Patients continue on study now ranging from 6 months up through 1 year.

Dr. Andrzej Jakubowiak, Director of the myeloma program at the University of Michigan Cancer Center, presented a poster entitled "A Multicenter Phase I Trial of Perifosine (KRX-0401) in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma: Preliminary Results. Multiple Myeloma Research Consortium (MMRC) Trial", demonstrating early encouraging results, with 50% of patients achieving a partial response or better.

Commenting on the data, Dr. Richardson stated, "Perifosine's potential in combination with bortezomib, dexamethasone and other novel therapies to overcome drug-resistant multiple myeloma is promising. Our team of investigators, including top centers across the country and now incorporating the considerable resources of the MMRC for one of the trials, is committed to completing enrollment in our studies and evaluating future clinical strategies to improve patient outcome."

Perifosine in the treatment of Patients with Relapsed/Refractory Waldenstrom's Macroglobulinemia:

A poster entitled "A Phase II Trial of Perifosine (KRX-0401) in Relapsed and/or Refractory Wald
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
2. AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
(Date:5/5/2015)... , Spanien, May 6, 2015 /PRNewswire/ ... Sparte Veterinärmedizin von ESTEVE will ... eine führende Rolle auf dem europäischen Markt ... Zusammenschluss übernimmt ECUPHAR alle Vermögensgüter und Beschäftigten ... Wochen dem neuen Unternehmen angegliedert werden. Da ...
(Date:5/5/2015)... 5, 2015  CorMedix Inc. (NYSE MKT: CRMD), a ... for the treatment of infectious diseases, announced that it ... 7.  Randy Milby , Chief Executive Officer of ... May 8 at 9:00 a.m. EDT.  ... call 1-877-407-8031 (U.S.), 1-201-689-8031 (outside the U.S.). All participants ...
(Date:5/5/2015)... 2015 Silver Creek Pharmaceuticals, Inc. announced today ... grant from the National Institute of Health (NIH). ... Francisco based biotechnology company that discovers and ... by disease. This award will be used to advance ... following a heart attack. Silver Creek,s Smart ...
Breaking Medicine Technology:ECUPHAR tritt mit ESTEVE in den spanischen und südamerikanischen Markt ein 2CorMedix, Inc. to Report First Quarter Financial Results on May 8, 2015 2Silver Creek Pharmaceuticals Awarded NIH SBIR Grant for Smart Growth Factor Technology 2
... 1, 2011 For the first ... endoscopic spinal surgery, showing the novel pain therapy ... endoscopic facet joint denervation, otherwise known as rhizotomy. ... launched in spring 2011, it completes the joimax® ...
... Time comes to an end on Sunday, Nov. 6, and adjusting ... Americans say that they experience a sleep problem every night or ... in America poll, and for those individuals the time change can ... into bed for not only an extra hour, but stay asleep ...
Cached Medicine Technology:joimax® Launches Numerous Innovations at NASS Chicago From November 2 - 4, 2011 2Keep the Time Change From Disrupting Your Rest With Sleep Formula 39™ 2
(Date:5/6/2015)... 2015 LINET Americas has been awarded ... the small business category. The award was given for ... Award is given on an annual basis to foreign ... contributions to philanthropy. Since 1998, the Charlotte International ... the Mayor’s International Community Awards. The award was presented ...
(Date:5/6/2015)... 06, 2015 “ Radiation Island ” was ... takes a look at the latest and coolest applications on ... host of AppWatch and technology expert, conducted the app review ... best graphic games on iOS. , Touted as one of ... It’s loved by users, which is obvious because of its ...
(Date:5/5/2015)... With ProPoint: Hand Drawn, users can point, underline, ... X . With ProPoint: Hand Drawn, users can also ... customize each preset all with a click of a mouse. ... fully customizable effect presets all within Final Cut Pro X. ... underlines, and more. , ProPoint: Hand Drawn on-screen controls ...
(Date:5/5/2015)... The Journal of Pain Research ... to improve the management of chronic non-cancer pain ... ACCORD program ” , As corresponding author Professor ... patients and family members, managers, and researcher, identified ... gap, “work in silos”, lack of awareness regarding ...
(Date:5/5/2015)... 2015 “Given that Hispanics are one in ... CDC report are a major step in the arsenal of ... For the past 30 years, data have accumulated that the ... we see the urgency and the need to create new ... outcomes for all,” said Jane L. Delgado, PhD, MS, President ...
Breaking Medicine News(10 mins):Health News:LINET Americas Wins The Mayor's International Community Award in Charlotte 2Health News:Top Grossing iPhone Game, Radiation Island, Was Featured on NewsWatch 2Health News:FCPX Plugin Developer Pixel Film Studios release Propoint Hand Drawn 2Health News:Priority interventions in chronic non-cancer pain published by Dove Medical Press 2Health News:“Its about time,” Declares the National Alliance for Hispanic Health on First CDC Study of Hispanic Health 2
... Clarient, Inc. (Nasdaq: CLRT ... pathologists, oncologists and the pharmaceutical industry, today announced that the Company ... Investments reconstitutes its comprehensive set of U.S. and global equity indices ... June 12 on www.russell.com . , , ...
... to hit market in September , , BOSTON, June 29 ... Times bestselling author and renowned wellness coach from NBC,s ... of weight-loss products in partnership with ThinCare(TM) International, LLC. The new ... Drug Stores Marketplace in Boston, Massachusetts on June 29, 2009. Scientifically ...
... , ... keep your pet healthy and happy and is more likely to avoid serious and costly health ... , ... pet health care can prevent expensive vet bills in the future, pet owners are reminded, as everyone ...
... ... an authorized representative agreement with SupplyCore Middle East (SCME). The agreement allows SCME to ... Medical decontamination equipment throughout the Middle East and North Africa (MENA). , ... (Vocus) June 29, 2009 -- ...
... ... MD Now Urgent Care: MD Now Urgent Care Medical Centers of Palm Beach County Florida has ... by the Urgent Care Association of America. , ... Palm Beach Gardens, FL (PRWEB) June 29, 2009 -- MD Now Urgent Care Medical Centers ...
... ... new coalition under the leadership of Matthias Rath, MD, is spearheading an online grass roots ... the rights of Americans to access safe, science-based, natural health alternatives. , ... Santa Clara, CA (PRWEB) June 29, 2009 -- ...
Cached Medicine News:Health News:Clarient Set to Join Russell 3000 Index 2Health News:Clarient Set to Join Russell 3000 Index 3Health News:Clarient Set to Join Russell 3000 Index 4Health News:Jillian Michaels, 'America's Toughest Trainer,' Announces New Line of Weight-Loss Supplements 2Health News:Jillian Michaels, 'America's Toughest Trainer,' Announces New Line of Weight-Loss Supplements 3Health News:Proactive Pet Care Essential in Low Cash Times, Says NOAH 2Health News:Proactive Pet Care Essential in Low Cash Times, Says NOAH 3Health News:Midbrook Partners with Supply Core Middle East to Provide Water Bottling and Medical Decontamination Equipment to the Middle East and North Africa 2Health News:Midbrook Partners with Supply Core Middle East to Provide Water Bottling and Medical Decontamination Equipment to the Middle East and North Africa 3Health News:MD Now Urgent Care Centers: First in Florida to Receive UCAOA Certification in Urgent Care 2Health News:MD Now Urgent Care Centers: First in Florida to Receive UCAOA Certification in Urgent Care 3Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 2Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 3Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 4Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 5
... RNA from agarose gels to hybridization membranes ... speed and efficiency of transfer by allowing ... ,Part of an integrated system allowing electrophoresis, ... 2.5 hours, versus 29 hours required for ...
PosiBlot 30-30 Masks...
... Rapid Downward Transfer Kit High resolution ... hour., Rapid ,Unique downward capillary ... hour and neutral ,(SSC) transfers in three ... device requires less buffer and blotting paper. ...
... of using the Antigen-Antibody Pens-Using a proprietary ... developed specialized fountain pens, called Antigen-Antibody pens-TM, ... write/mark the blotting membranes in any form ... antigen-bonded colored dyes helps to see antigen ...
Medicine Products: